Responses
Oral presentations
159 Pharmacokinetics (PKS) of Levosimendan (LEVO) and Intermediate Metabolites (OR-1855 and OR-1896) in Newborns Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass (CPB)
Compose a Response to This Article
Other responses
No responses have been published for this article.